Data_Sheet_1_Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.docx
Background: Patient involvement is often acknowledged as an important aspect of the lifecycle of medicines. Although different typologies exist, patient involvement has been described as the involvement of patients in decision-making regarding medicines. In view of the diversity of stakeholders and types of decisions in which patients might be involved, an in-depth understanding of these stakeholders' views toward involving patients in the lifecycle of medicines is essential. Methods: Interviews and surveys were used to gain insights into the perspectives and experiences of Belgian healthcare... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Dataset |
Erscheinungsdatum: | 2018 |
Schlagwörter: | Dermatology / Emergency Medicine / Gastroenterology and Hepatology / Geriatrics and Gerontology / Intensive Care / Medical Genetics (excl. Cancer Genetics) / Nephrology and Urology / Nuclear Medicine / Orthopaedics / Otorhinolaryngology / Pathology (excl. Oral Pathology) / Radiology and Organ Imaging / Foetal Development and Medicine / Obstetrics and Gynaecology / Family Care / Primary Health Care / Medical and Health Sciences not elsewhere classified / patient involvement / decision-making / lifecycle of medicines / patient preferences / evaluation of medicines / reimbursement / medicines development / market access |
Sprache: | unknown |
Permalink: | https://search.fid-benelux.de/Record/base-28886852 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.3389/fmed.2018.00285.s001 |